EP3219705
Lyfjasamsetningar af myndlausa forminu af N-[2,4-bis(1,1-dímetýletýl)-5-hýdróxýfenýl]-1,4-díhýdró-4-oxókínólín-3-karbóxamíð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.12.2006EP published:
11.3.2020EP application number:
17154944.7
EP translation filed:
2.4.2020Grant published:
15.4.2020EPO information:
European Patent Register
Max expiry date:
27.12.2026Expiry date:
27.12.2026
Title:
PHARMACEUTICAL COMPOSITIONS OF THE AMORPHOUS FORM OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE
Timeline
Today
28.12.2006EP application
11.3.2020EP Publication
2.4.2020Translation submitted
15.4.2020Registration published
27.12.2026Expires
Owner
Name:
Vertex Pharmaceuticals IncorporatedAddress:
50 Northern Avenue, Boston, MA 02210, US
Inventor
Name:
HURTER, PatriciaAddress:
Harvard, MA 01451, US
Name:
GONG, YuchuanAddress:
Lexington, MA 02421, US
Name:
YOUNG, Christopher R.Address:
Waltham, MA 02451, US
Name:
CONNELLY, PatrickAddress:
Harvard, MA 01451, US
Name:
ROWE, WilliamAddress:
Medford, MA 02155, US
Name:
COSTACHE, AdrianaAddress:
Roslindale, MA 02131, US
Name:
KRAWIEC, MariuszAddress:
Marlborough, MA 01752, US
Name:
FENG, YushiAddress:
Maldon, MA 02148, US
Name:
TRUDEAU, MartinAddress:
Shannon, Québec G0A 4N0, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
754381 PDate:
28.12.2005Country:
US
Classification
Categories:
C07D 215/56, A61K 31/445
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 1.12.2020
Expires: 27.12.2021
Payer: Sigurjónsson & Thor ehf.
Number: 16
Paid: 1.12.2021
Expires: 27.12.2022
Payer: Sigurjónsson & Thor ehf.
Number: 17
Paid: 15.1.2023
Expires: 27.12.2023
Payer: Árnason Faktor ehf.
Number: 18
Paid: 15.12.2023
Expires: 27.12.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 15.12.2023
Expires: 27.12.2024
Payer: Árnason Faktor ehf.
Number: 19
Paid: 10.12.2024
Expires: 27.12.2025
Payer: Árnason Faktor ehf.
Number: 20
Paid: 19.12.2025
Expires: 27.12.2026
Payer: Árnason Faktor ehf.